ResMed Inc. sees major investment from Nykredit A S

ResMed Inc., a global medical equipment provider specializing in sleep apnea treatments and respiratory care, has seen significant institutional activity. Nykredit A S disclosed a new position in the company during the second quarter, acquiring 338,702 shares valued at approximately $66,006,000, bringing its ownership to 0.23%.

ResMed, which was founded in Australia and is now based in San Diego, operates through two primary units: Sleep and Respiratory Care, and Software as a Service (SaaS). The company provides CPAP machines and cloud-connectable software used in home medical equipment. While the company maintains a presence in over 140 countries, its shares are listed on both the NYSE and the ASX.

Despite recent fluctuations in share price, analysts have provided mixed outlooks. Recent reports include a neutral rating from Rothschild & Co Redburn and Piper Sandler, an overweight rating from KeyCorp, and an equal weight rating from Wells Fargo & Company.